Alcoholism, which is defined by the recurring harmful use of alcohol despite its negative consequences, has lifetime prevalence of 10% and socially serious problem. Accumulating evidence indicate that alcoholism is often comorbid with schizophrenia and these diseases have common genetic risk factors and pathophysiology, such as hypoglutamatergic and hyperdopaminergic activities in the brain.
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Effects of chronic tryptophan depletion on autism spectrum disorder like behaviors in serotonin transporter knockout and heterozygous mice Abstract Autistic spectrum disorder (ASD), according to DSM-5, is a severe neurodevelopmental disorder characterized by persistent deficits in social communication and interaction with by restricted, repetitive patterns from early childhood. ASD affects about 1.0 % of the population. Several lines of evidence support the relationship between the serotonin hypothesis and ASD because some patients with ASD contains high serotonin level in the blood. The serotonin blood concentration is adjusted by serotonin transporter (SERT), and it is thought that SERT function is declining in ASD patients. In this study, we examined social interaction test and 3 chamber test in wild type (WT), SERT heterozygous (HZ) and SERT knockout (KO) mice on a C57BL/6J genetic background to assess the ASD like behaviors. Furthermore, we investigated the effects of food lacing tryptophan to measure of serotonin. The Mice in each genotype were randomly divided into two groups: control mice, tryptophan deficiency mice, and we conducted the same tests for ASD like behaviors. We found that KO and HZ mice showed low sniffing on novel mouse compared with WT mice in the social interaction test and showed reduced social preference in the 3 chamber test. KO and HZ mice that had taken tryptophan depletion food showed decreased abnormal behaviors. Our findings suggest that KO and HZ mice have deficits in social interaction and tryptophan depletion may improve these abnormal behaviors.
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Neuroactive steroid treatment in the model of focal cerebra ischemia in immature brain 
Abstract
The age group with the highest risk of ischemic stroke is elderly population, but it affects also newborns. Hypoxic-ischemic state is the most common form of perinatal brain damage. This pathological state in early age can lead to permanent neurological consequences.
On the other hand, recently published experimental data and clinical observations suggested that neurosteroids concentration increase shortly before born. This finding gives rise to the possibility of obtaining the drugs with neuroprotective properties and minimal side effect
The data suggests that perinatal hypoxic-ischemic state induces inflammation and oxidative stress and can influence normal brain development. These processes are insufficiently explored in immature brain, and it is little known about their role in ischemia-induced outcome. Recently, positive outcome of a neurosteroid treatment, due to an anti-inflammatory effect, was shown in models of epilepsy and ischemia.
Aim of the study is to study neuroprotective and anti-inflammatory effect of neuroactive steroids in a model of focal cerebral ischemia (FCI) in immature rat brain.
FCI was induced by the infusion of the endothelin-1 (ET1, 40 pmol) into the right dorsal hippocampus of 12-days-old rats (P12). The neuroactive steroid 3α5β-pregnanolone glutamate (PG, 1mg/ kg, i.p.) was applied 5 min after the ET-1 infusion. Effect of the treatment was evaluated by neurochemical monitoring using the microdialysis technique during two hours after ET-1 infusion. In addition, in material obtained 24h after FCI, immunoblotting and immunohistochemistry methods were used to assess ischemiainduced changes and determine effect of PG-treatment.
The treatment with the neuroactive steroid PG leads to reduction of the ischemia induced injury in neural tissue,
